The Fred Report - Sector Review March 2017

View a Printer Friendly version of this page, allowing you to print the page.

XLV and IYZ remain under weights. XLV improved a lot but the chart is worse than other sectors and the accumulation model remains weak. Note that there is no Biotech in XLV, so the improvement there is not helping this area.



Sorry this page is available to subscribers only.
If you're not a subscriber why not join today?

If you are already a subscriber, please login.

If you believe you should be able to view this area, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

 

 

 

Who is Fred Meissner, CMT?
Listen here:

The FRED Report is not authorized, endorsed, or affiliated with the Federal Reserve of St Louis and its FRED Economic Data.